Home › Funds › KVP Capital Advisors, LP › VYNE
KVP Capital Advisors, LP position in VYNE
VYNE THERAPEUTICS INC
KVP Capital Advisors, LP reported holding 500,551 shares of VYNE (VYNE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$326K, representing 0.24% of its reported portfolio and ranking #35 among its reported holdings. KVP Capital Advisors, LP has disclosed VYNE holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How KVP Capital Advisors, LP's VYNE position evolved
KVP Capital Advisors, LP first disclosed a stake in VYNE in Q4 2025 at 500,551 shares (US$290K). The position peaked in Q2 2026 at 500,551 shares, worth US$326K. Across 3 filings, KVP Capital Advisors, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 500,551 shares valued at US$326K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 500.55K | $290.37K | New |
| Q1 2026 | 500.55K | $299.08K | Hold |
| Q2 2026 | 500.55K | $325.71K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VYNE and 13F data
VYNE (VYNE THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 28 other funds we track also report a position in VYNE — the largest reported positions include Lynx1 Capital Management LP (US$1.1M), SUPERSTRING CAPITAL MANAGEMENT LP (US$40K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VYNE
- Lynx1 Capital Management LP 1.63M sh · $1.06M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 61.27K sh · $39.87K · Q2 2026
More on KVP Capital Advisors, LP
FAQ
How long has KVP Capital Advisors, LP held VYNE?
KVP Capital Advisors, LP has disclosed VYNE holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is KVP Capital Advisors, LP's current position in VYNE?
As of Q2 2026, KVP Capital Advisors, LP holds 500.55K shares of VYNE (VYNE THERAPEUTICS INC), valued at $325.71K, representing 0.24% of its reported portfolio and ranking #35.
Has KVP Capital Advisors, LP been buying or selling VYNE?
In the latest 13F filing (Q2 2026), KVP Capital Advisors, LP held unchanged its position in VYNE. The position peaked in Q2 2026 at 500.55K shares.
Which other funds hold VYNE?
Other major institutional holders of VYNE include Lynx1 Capital Management LP, SUPERSTRING CAPITAL MANAGEMENT LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.